Skip to main content
Clinical Trials/IRCT20210919052520N1
IRCT20210919052520N1
Recruiting
Early Phase 1

Evaluation of the therapeutic effect of nebulized addipose tissue- derived mesenchymal stem cells conditioned media on covid -19 pneumonia

Kerman University of Medical Sciences0 sites15 target enrollmentTBD

Overview

Phase
Early Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Kerman University of Medical Sciences
Enrollment
15
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with Covid 19 who have been infected for a week and who have been hospitalized for 48 hours despite receiving medication and oxygen have not improved their condition and their arterial blood oxygen saturation percentage is below 88%.

Exclusion Criteria

  • Patients with arterial blood oxygen saturation above 88%.

Outcomes

Primary Outcomes

Not specified

Similar Trials